Skip to main content
Erschienen in: Pediatric Cardiology 4/2019

04.03.2019 | Original Article

Relationship Between Pulmonary Arterial Resistance and Compliance in Patients with Down Syndrome

verfasst von: Yuka Iwaya, Jun Muneuchi, Yuka Inoue, Mamie Watanabe, Seigo Okada, Yoshie Ochiai

Erschienen in: Pediatric Cardiology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to clarify the characteristics of pulmonary arterial resistance (Rp)–compliance (Cp) coupling in individuals with Down syndrome (DS), who have increased risks of pulmonary arterial hypertension (PAH). We performed cardiac catheterization before and after corrective surgery in 85 DS infants and 85 controls with congenital heart disease and PAH. We retrospectively collected hemodynamic data and compared Rp and Cp between the groups. Age at surgery was 3.5 (2.6–4.6) months. The first and second catheterizations were performed 1 month before and after corrective surgery in both groups. Preoperative Cp in DS patients was significantly lower than that in controls [2.27 (1.62–3.0) vs. 2.50 (1.86–3.31) mL/mmHg/m2, p = 0.039], although there was no significant difference in mean pulmonary arterial pressure and Rp between the groups. Analysis of covariance revealed that the slopes of the preoperative regression lines for the logarithmic transformations of Rp and Cp were identical in DS patients and controls (p = 0.299). However, the postoperative regression line was shifted downward in DS patients after corrective surgery. Postoperative home oxygen therapy (HOT) was performed in 39 patients (36 DS patients) and multivariate logistic regression analysis revealed that postoperative HOT was significantly related to low preoperative Cp (p = 0.039) and DS (p = 0.0001). Individuals with DS have the unique pulmonary vasculature characterized with low Cp that is related to postoperative HOT.
Literatur
1.
Zurück zum Zitat Chi TPL, Krovetz J (1975) The pulmonary vascular bed in children with Down syndrome. J Pediatr 86:533–538CrossRef Chi TPL, Krovetz J (1975) The pulmonary vascular bed in children with Down syndrome. J Pediatr 86:533–538CrossRef
2.
Zurück zum Zitat King P, Tulloh R (2011) Management of pulmonary hypertension and Down syndrome. Int J Clin Pract Suppl 174:8–13CrossRef King P, Tulloh R (2011) Management of pulmonary hypertension and Down syndrome. Int J Clin Pract Suppl 174:8–13CrossRef
3.
Zurück zum Zitat Cooney TP, Thurlbeck WM (1982) Pulmonary hypoplasia in Down’s syndrome. N Engl J Med 307:1170–1173CrossRefPubMed Cooney TP, Thurlbeck WM (1982) Pulmonary hypoplasia in Down’s syndrome. N Engl J Med 307:1170–1173CrossRefPubMed
4.
Zurück zum Zitat Yamaki S, Horiuchi T, Sekino Y (1983) Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome. Am J Cardiol 51:1502–1506CrossRefPubMed Yamaki S, Horiuchi T, Sekino Y (1983) Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome. Am J Cardiol 51:1502–1506CrossRefPubMed
5.
Zurück zum Zitat de Miguel-Díez J, Villa-Asensi JR, Alvarez-Sala JL (2003) Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep 26:1006–1009CrossRefPubMed de Miguel-Díez J, Villa-Asensi JR, Alvarez-Sala JL (2003) Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep 26:1006–1009CrossRefPubMed
6.
Zurück zum Zitat Cua CL, Rogers LK, Chicoine LG, Augustine M, Jin Y, Nash PL, Nelin LD (2011) Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine. Eur J Pediatr 170:859–863CrossRefPubMed Cua CL, Rogers LK, Chicoine LG, Augustine M, Jin Y, Nash PL, Nelin LD (2011) Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine. Eur J Pediatr 170:859–863CrossRefPubMed
7.
Zurück zum Zitat Fukushima H, Kosaki K, Sato R, Yagihashi T, Gatayama R, Kodo K, Hayashi T, Nakazawa M, Tsuchihashi T, Maeda J, Kojima Y, Yamagishi H, Takahashi T (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A 152:1919–1924CrossRef Fukushima H, Kosaki K, Sato R, Yagihashi T, Gatayama R, Kodo K, Hayashi T, Nakazawa M, Tsuchihashi T, Maeda J, Kojima Y, Yamagishi H, Takahashi T (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A 152:1919–1924CrossRef
8.
Zurück zum Zitat Sagawa K, Lie RK, Schaefer J (1990) Translation of Otto Frank’s paper “Die Grundform des Arteriellen Pulses”. Zeitschrift für Biologie 37:483–526 (1899). J Mol Cell Cardiol 22:253–254.CrossRefPubMed Sagawa K, Lie RK, Schaefer J (1990) Translation of Otto Frank’s paper “Die Grundform des Arteriellen Pulses”. Zeitschrift für Biologie 37:483–526 (1899). J Mol Cell Cardiol 22:253–254.CrossRefPubMed
9.
Zurück zum Zitat Muneuchi J, Nagatomo Y, Watanabe M, Joo K, Onzuka T, Ochiai Y, Joo K (2016) Relationship between pulmonary arterial resistance and compliance among patients with pulmonary arterial hypertension and congenital heart disease. J Thorac Cardiovasc Surg 152:507–513CrossRefPubMed Muneuchi J, Nagatomo Y, Watanabe M, Joo K, Onzuka T, Ochiai Y, Joo K (2016) Relationship between pulmonary arterial resistance and compliance among patients with pulmonary arterial hypertension and congenital heart disease. J Thorac Cardiovasc Surg 152:507–513CrossRefPubMed
10.
Zurück zum Zitat Hoashi T, Hirahara N, Murakami A, Hirata Y, Ichikawa H, Kobayashi J, Takamoto S (2017) Current surgical outcomes of congenital heart surgery for patients with Down Syndrome in Japan. Circ J 82:403–408CrossRefPubMed Hoashi T, Hirahara N, Murakami A, Hirata Y, Ichikawa H, Kobayashi J, Takamoto S (2017) Current surgical outcomes of congenital heart surgery for patients with Down Syndrome in Japan. Circ J 82:403–408CrossRefPubMed
11.
Zurück zum Zitat Kumar B, Puri GD, Manoj R, Gupta K, Shyam KS (2011) Severe pulmonary artery hypertension following intracardiac repair of tetralogy of Fallot: an unusual finding. Pulm Circ 11:115–118CrossRef Kumar B, Puri GD, Manoj R, Gupta K, Shyam KS (2011) Severe pulmonary artery hypertension following intracardiac repair of tetralogy of Fallot: an unusual finding. Pulm Circ 11:115–118CrossRef
12.
Zurück zum Zitat Muneuchi J, Oda S, Shimizu D (2017) Rapidly progressive pulmonary veno-occulusive disease in an infant with Down syndrome. Cardiol Young 27:1402–1405CrossRefPubMed Muneuchi J, Oda S, Shimizu D (2017) Rapidly progressive pulmonary veno-occulusive disease in an infant with Down syndrome. Cardiol Young 27:1402–1405CrossRefPubMed
13.
Zurück zum Zitat Takatsuki S, Nakayama T, Ikehara S, Matsuura H, Ivy DD, Saji T (2017) Pulmonary arterial capacitance index is a strong predictor for adverse outcome in children with idiopathic and heritable pulmonary arterial hypertension. J Pediatr 180:75–79CrossRefPubMed Takatsuki S, Nakayama T, Ikehara S, Matsuura H, Ivy DD, Saji T (2017) Pulmonary arterial capacitance index is a strong predictor for adverse outcome in children with idiopathic and heritable pulmonary arterial hypertension. J Pediatr 180:75–79CrossRefPubMed
14.
Zurück zum Zitat Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R (2006) Obstructive sleep apnea: should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg 132:432–436CrossRefPubMed Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R (2006) Obstructive sleep apnea: should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg 132:432–436CrossRefPubMed
15.
Zurück zum Zitat Jacobs IN, Teague WG, Bland JW Jr (1997) Pulmonary vascular complications of chronic airway obstruction in children. Arch Otolaryngol Head Neck Surg 123:700–704CrossRefPubMed Jacobs IN, Teague WG, Bland JW Jr (1997) Pulmonary vascular complications of chronic airway obstruction in children. Arch Otolaryngol Head Neck Surg 123:700–704CrossRefPubMed
16.
Zurück zum Zitat Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM (2011) Management of pulmonary hypertension in Down syndrome. Eur J Pediatr 170:915–921CrossRefPubMed Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM (2011) Management of pulmonary hypertension in Down syndrome. Eur J Pediatr 170:915–921CrossRefPubMed
17.
Zurück zum Zitat Saji T (2014) Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int 56:297–303CrossRefPubMed Saji T (2014) Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int 56:297–303CrossRefPubMed
18.
Zurück zum Zitat Suzuki K, Yamaki S, Mimori S, Murakami Y, Mori K, Takahashi Y, Kikuchi T (2000) Pulmonary vascular disease in Down’s syndrome with complete atrioventricular septal defect. Am J Cardiol 86:434–437CrossRefPubMed Suzuki K, Yamaki S, Mimori S, Murakami Y, Mori K, Takahashi Y, Kikuchi T (2000) Pulmonary vascular disease in Down’s syndrome with complete atrioventricular septal defect. Am J Cardiol 86:434–437CrossRefPubMed
19.
Zurück zum Zitat Galambos C, Minic AD, Bush D, Nguyen D, Dodson B, Seedorf G, Abman SH (2016) Increased lung expression of anti-angiogenic factors in down syndrome: potential role in abnormal lung vascular growth and the risk for pulmonary hypertension. PLoS ONE 11:e0159005CrossRefPubMedPubMedCentral Galambos C, Minic AD, Bush D, Nguyen D, Dodson B, Seedorf G, Abman SH (2016) Increased lung expression of anti-angiogenic factors in down syndrome: potential role in abnormal lung vascular growth and the risk for pulmonary hypertension. PLoS ONE 11:e0159005CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Fukushima H, Kosaki K, Sato R, Yagihashi T, Gatayama R, Kodo K, Hayashi T, Nakazawa M, Tsuchihashi T, Maeda J, Kojima Y, Yamagishi H, Takahashi T (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A 152A:1919–1924CrossRefPubMed Fukushima H, Kosaki K, Sato R, Yagihashi T, Gatayama R, Kodo K, Hayashi T, Nakazawa M, Tsuchihashi T, Maeda J, Kojima Y, Yamagishi H, Takahashi T (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A 152A:1919–1924CrossRefPubMed
21.
Zurück zum Zitat Kageyama K, Hashimoto S, Nakajima Y, Shime N, Hashimoto S (2007) The change of plasma endothelin-1 levels before and after surgery with or without Down syndrome. Paediatr Anaesth 17:1071–1077PubMed Kageyama K, Hashimoto S, Nakajima Y, Shime N, Hashimoto S (2007) The change of plasma endothelin-1 levels before and after surgery with or without Down syndrome. Paediatr Anaesth 17:1071–1077PubMed
22.
Zurück zum Zitat Okada S, Muneuchi J, Nagatomo Y, Watanabe M, Iida C, Shirouzu H, Matsuoka R, Joo K (2017) Pulmonary arterial resistance and compliance in preterm infants. Int J Cardiol 244:265–270CrossRefPubMed Okada S, Muneuchi J, Nagatomo Y, Watanabe M, Iida C, Shirouzu H, Matsuoka R, Joo K (2017) Pulmonary arterial resistance and compliance in preterm infants. Int J Cardiol 244:265–270CrossRefPubMed
Metadaten
Titel
Relationship Between Pulmonary Arterial Resistance and Compliance in Patients with Down Syndrome
verfasst von
Yuka Iwaya
Jun Muneuchi
Yuka Inoue
Mamie Watanabe
Seigo Okada
Yoshie Ochiai
Publikationsdatum
04.03.2019
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 4/2019
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-019-02080-9

Weitere Artikel der Ausgabe 4/2019

Pediatric Cardiology 4/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.